Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
In this article:
The drug is one of an emerging class of drugs that has drawn the interest of large pharma companies.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
The drug is one of an emerging class of drugs that has drawn the interest of large pharma companies.